CREATIC at Prague.bio Conference 2025: Connecting Innovation, Collaboration and the Future of Advanced Therapies
The Prague.bio Conference 2025 brought together the energy, ideas and collaborative spirit that continue to drive progress across the biotech sector in Central Europe. Held in Prague on 25 September 2025, the third edition of the conference welcomed researchers, startups, investors and industry experts for a full day of discussions on drug development, diagnostics, medical technologies, innovation transfer and commercialization.
For the CREATIC team, the conference was an inspiring opportunity to present our mission and engage with a community that shares our ambition to move cutting edge science closer to patients. Throughout the event, we introduced CREATIC’s work in accelerating the development of cell and gene therapies for rare diseases and highlighted the importance of building strong bridges between research, clinical application and long term patient access. This focus closely matched the wider conference programme, which combined scientific exchange with pitch sessions, panel discussions and networking opportunities designed to support innovation across the biotech ecosystem.
During the conference, CREATIC contributed through both a workshop and a series of engaging pitch sessions. These formats created valuable space to present our work, discuss shared challenges and explore future collaborations with partners from across the field. The atmosphere throughout the day clearly showed that progress in advanced therapies depends not only on scientific excellence, but also on openness, partnership and the ability to connect diverse expertise.
What stood out most was the strong sense of momentum across the entire event. Prague.bio Conference 2025 was designed as a meeting point for science and business, with more than 400 experts expected to attend and a programme aimed at connecting promising research with investment, development and practical application.
For CREATIC, this made the conference especially relevant. Our mission goes beyond research alone. We are working to help accelerate the development of advanced therapies that can address serious unmet medical needs, especially in the field of rare diseases. Events such as Prague.bio provide an important platform to share this vision, to learn from others, and to strengthen the relationships that are essential for turning innovation into real therapeutic progress.
We are grateful for every discussion that took place during the conference, from informal conversations to more focused exchanges about future projects and possible cooperation. The day confirmed that there is a remarkable amount of expertise, creativity and determination across the region, and that meaningful progress happens fastest when these strengths come together.
Prague.bio Conference 2025 once again demonstrated that the future of biotechnology will be shaped not only by breakthrough ideas, but also by collaboration across institutions, disciplines and sectors. We are proud to have been part of this inspiring event and look forward to continuing the conversations that started there.